Cellebrite DI Ltd. Capitalized Contract Cost, Impairment Loss
Cellebrite DI Ltd. (CLBT) reported Capitalized Contract Cost, Impairment Loss of $0 for the 12-month period ending 2021-12-31, per its 20-F filed 2022-03-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CapitalizedContractCostImpairmentLoss · last filed 2022-03-29
| Period end | Capitalized Contract Cost, Impairment Loss 12 month |
|---|---|
| 2021-12-31 | $0.00 20-F · filed 2022-03-29 |
| 2020-12-31 | $0.00 20-F · filed 2022-03-29 |